ONCAlert | Upfront Therapy for mRCC

Augmenting T Cell Immunity in Cold Tumors

Stephanie K. Dougan, MD
Published Online: 7:31 PM, Sat November 10, 2018

Stephanie K. Dougan, MD, assistant professor, Dana-Farber Cancer Institute and Harvard Medical School, discusses the idea of augmenting T cell immunity in tumors that are poorly immunogenic, such as pancreatic cancer.

Copyright © TargetedOnc 2019 Intellisphere, LLC. All Rights Reserved.